1
|
Alhakamy NA, Saquib M, Sanobar, Khan MF, Ansari WA, Arif DO, Irfan M, Khan MI, Hussain MK. Natural product-inspired synthesis of coumarin-chalcone hybrids as potential anti-breast cancer agents. Front Pharmacol 2023; 14:1231450. [PMID: 37745072 PMCID: PMC10511752 DOI: 10.3389/fphar.2023.1231450] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2023] [Accepted: 08/18/2023] [Indexed: 09/26/2023] Open
Abstract
Twelve novel neo-tanshinlactone-chalcone hybrid molecules were constructed through a versatile methodology involving the Horner-Wadsworth-Emmons (HWE) olefination of 4-formyl-2H-benzo [h]chromen-2-ones and phosphonic acid diethyl esters, as the key step, and evaluated for anticancer activity against a series of four breast cancers and their related cell lines, viz. MCF-7 (ER + ve), MDA-MB-231 (ER-ve), HeLa (cervical cancer), and Ishikawa (endometrial cancer). The title compounds showed excellent to moderate in vitro anti-cancer activity in a range of 6.8-19.2 µM (IC50). Compounds 30 (IC50 = 6.8 µM and MCF-7; IC50 = 8.5 µM and MDA-MB-231) and 31 (IC50 = 14.4 µM and MCF-7; IC50 = 15.7 µM and MDA-MB-231) exhibited the best activity with compound 30 showing more potent activity than the standard drug tamoxifen. Compound 30 demonstrated a strong binding affinity with tumor necrosis factor α (TNF-α) in molecular docking studies. This is significant because TNFα is linked to MCF-7 cancer cell lines, and it enhances luminal breast cancer cell proliferation by upregulating aromatase. Additionally, virtual ADMET studies confirmed that hybrid compounds 30 and 31 met Lipinski's rule; displayed high bioavailability, excellent oral absorption, favorable albumin interactions, and strong penetration capabilities; and improved blood-brain barrier crossing. Based on the aforementioned results, compound 30 has been identified as a potential anti-breast cancer lead molecule.
Collapse
Affiliation(s)
- Nabil A. Alhakamy
- Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia
- Mohamed Saeed Tamer Chair for Pharmaceutical Industries, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia
- Center of Excellence for Drug Research and Pharmaceutical Industries, King Abdulaziz University, Jeddah, Saudi Arabia
| | - Mohammad Saquib
- Department of Chemistry, University of Allahabad, Prayagraj, India
| | - Sanobar
- Department of Chemistry, Government Raza Post Graduate College, Rampur, India
- M. J. P. Rohilkhand University, Bareilly, India
| | - Mohammad Faheem Khan
- Department of Biotechnology, Era’s Lucknow Medical College, Era University, Lucknow, India
| | - Waseem Ahmad Ansari
- Department of Biotechnology, Era’s Lucknow Medical College, Era University, Lucknow, India
| | - Deema O. Arif
- Mohamed Saeed Tamer Chair for Pharmaceutical Industries, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia
- Center of Excellence for Drug Research and Pharmaceutical Industries, King Abdulaziz University, Jeddah, Saudi Arabia
- Faculty of Medicine, Ibn Sina National College, Jeddah, Saudi Arabia
| | - Mohammad Irfan
- Department of Medicine, Jawaharlal Nehru Medical College and Hospital, Aligarh Muslim University (AMU), Aligarh, India
| | - Mohammad Imran Khan
- Departments of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia
- Centre of Artificial Intelligence in Precision Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
| | - Mohd Kamil Hussain
- Department of Chemistry, Government Raza Post Graduate College, Rampur, India
- M. J. P. Rohilkhand University, Bareilly, India
| |
Collapse
|
2
|
Dong Y, Nakagawa-Goto K, Lai CY, Morris-Natschke SL, Bastow KF, Lee KH. Antitumor agents 287. Substituted 4-amino-2H-pyran-2-one (APO) analogs reveal a new scaffold from neo-tanshinlactone with in vitro anticancer activity. Bioorg Med Chem Lett 2011; 21:2341-4. [PMID: 21420855 PMCID: PMC3072684 DOI: 10.1016/j.bmcl.2011.02.084] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2010] [Revised: 02/18/2011] [Accepted: 02/22/2011] [Indexed: 10/18/2022]
Abstract
4-Amino-2H-benzo[h]chromen-2-one (ABO) and 4-amino-7,8,9,10-tetrahydro-2H-benzo[h]chromen-2-one (ATBO) analogs were found to be significant in vitro anticancer agents in our previous research. Our continuing study has now discovered a new simplified (monocyclic rather than tricyclic) class of cytotoxic agents, 4-amino-2H-pyran-2-one (APO) analogs. By incorporating various substituents on the pyranone ring, we have established preliminary structure-activity relationships (SAR). Analogs 19, 20, 23, and 26-30 displayed significant tumor cell growth inhibitory activity in vitro. The most active compound 27 exhibited ED(50) values of 0.059-0.090 μM.
Collapse
Affiliation(s)
- Yizhou Dong
- Natural Products Research Laboratories, UNC Eshelman School of
Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599-7568
| | - Kyoko Nakagawa-Goto
- Natural Products Research Laboratories, UNC Eshelman School of
Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599-7568
| | - Chin-Yu Lai
- Natural Products Research Laboratories, UNC Eshelman School of
Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599-7568
| | - Susan L. Morris-Natschke
- Natural Products Research Laboratories, UNC Eshelman School of
Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599-7568
| | | | - Kuo-Hsiung Lee
- Natural Products Research Laboratories, UNC Eshelman School of
Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599-7568
- Chinese Medicine Research and Development Center, China Medical
University and Hospital, Taichung, Taiwan
| |
Collapse
|